EDPS of Clinical Case Record and Scientific Document in the Industry Post-Marketing Surveillance of Drugs

Abstract

In order to meet the multifarious needs for drug information and to cope with the post-marketing surveillance of drugs adequately, an on-line drug information network, which is composed of two data bases, clinical case record data base and literature data base, has been developed. Primary considerations in designing these systems were input of clean data, accurate input, insuring that no ADRs are overlooked, accumulation of the latest data, saving manpower required for processing, and processing large quantities of data. This system is also designed to input and to output in Japanese character.

The Development and Practical Use of Information Systems in the Pharmaceutical Industry

“…We have compared our systems with others. However, there is only a limited number of detailed reports on literature information systems developed by other pharmaceutical companies [2,3,[12][13][14]. There is no detailed information on operation results by medical representatives in those papers.…”

“…In addition, the operation methods differ among the databases. Therefore, in Japan, pharmaceutical firms have developed since the 1980s [2,3] databases with their own literature information. We also developed our own literature information system (DOLlS: Daiichi Online Literature Information System), in 1983 [4].…”